SYNTEC OPTICS HOLDINGS, INC.

OPTX
About the company

Syntec Optics Holdings, Inc. manufactures and supplies optics and photonics components, sub-systems, and optical systems for defense, medical, industrial, and consumer end-markets in the United States and Europe. It offers polymer-based optics; and optical assemblies, electro-optics assemblies, molded polymer and glass optic components, opto-mechanical components, nano machining, and thin films coating. The company also provides optics assembly, electro-optics assembly, design, and coating services.

Country: United StatesPrice: $7.08Market Cap: $285.2M

Investment snapshot

0%positive consensus
Scored 1d ago

Positive

0

BUY / PASS

Neutral / negative

2 / 14

NEUTRAL / FAIL

Median fair value

$0.03

-99.5% vs price

Models with upside

0 / 17

Positive margin of safety

Strongest signal

10 of 12 pass — Buffett and Marks object

Key risk

No clean pass — all 16 investors flag at least one profitability criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILFAIL · Rank #1901 (Top 61.4%)NEUTRALFAILFAILFAILFAILFAILFAILFAILFAILFAILFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/A-11700.0%N/AN/AN/AN/A-70700.0%-661.3%N/AN/A-70700.0%N/AN/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Annual history · FY 2025

Latest source filing: 2026-08-10

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-06-30 · TTM ended 2026-06-30

Latest source filing: 2026-08-10

Score computed: 2026-11-14

TTM ended 2026-06-30

Latest source filing: 2026-08-10

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Market data at 2026-11-01

Latest source filing: 2026-08-10

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-10

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-06-30 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-10

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Market data at 2026-11-01

Latest source filing: 2026-08-10

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-10

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-31

Score computed: 2026-11-14

TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-08-10

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30

Latest source filing: 2026-08-10

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-10

Score computed: 2026-11-14

TTM ended 2026-06-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-08-10

Score computed: 2026-11-14

Where It Passes

  • Debt & Leverage83% pass✓ 13✗ 2▾

    10 of 12 pass — Buffett and Marks object

    LT Debt vs Net Current AssetsLT Debt $2.2M vs NCA $24.7M
    ✓GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 0.28, IC: -0.7x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0.09
    ✓Lynch< 0.33
    Cash - Long-term Debt$11.9M
    ✓LynchPositive preferred
    LT Debt / Total Assets Change10.05% -> 8.76%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities5.97
    ✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0.09
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Debt Levels0.09
    ✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=-0.7x, D/EBITDA=1.3x
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0.09
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.0905; #1232/4210 (top 29.3%)
    ✓AsnessTop 30% of eligible cross-section

Where It Falls Short

  • Profitability0% pass✓ 3✗ 32▾

    No clean pass — all 16 investors flag at least one profitability criterion

    Positive EPS (10 years)1/6 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)1/6 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-7.7%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)-1.8% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$0.2M
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE-7.9%
    ✗Lynch> 15%
    EBIT / Enterprise Value-0.5%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-0.5%, ROC=-6.6%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets-7.38%
    ✗PiotroskiROA > 0
    ROA Change YoY-9.53% -> -7.38% (delta: +2.16%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=2.77%, ROA=-7.38%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY20.0% -> 23.3%
    ✓PiotroskiImproved YoY
    Pre-Tax Income / Revenue-6.8%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity-7.9%
    ✗Dreman> 12%
    Margin of SafetyP/B=27.5x
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity-8.7% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency1/4 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue-4.6%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity-7.9%
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend5.2% (2023) -> -1.8% (2025)
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 26.9% -> 23.3%, operating margin 5.2% -> -1.8%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization-0.85%; #3383/6340 (top 53.4%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+14.75%; #2440/3702 (top 65.9%)
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity-7.92%; #3330/5226 (top 63.7%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0656; #2917/5884 (top 49.6%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Valuation0% pass✗ 28▾

    All 13 investors flag OPTX's valuation

    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio27.5x
    ✗Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value-0.5%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-0.5%, ROC=-6.6%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)389.4x
    ✗Dreman< 8x
    Price / Book Value per Share27.5x
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessOE Yield=0.1%
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldFCF Yield=0.0%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/B=27.5x
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share9241.0x
    ✗Ackman<= 25
    Price vs. Trailing Low585% of trailing low ($1.21)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization-0.85%; #3383/6340 (top 53.4%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+0.1069; #4705/6449 (top 73.0%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share27.45x
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change-13.8%
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+0.1025; #4327/5247 (top 82.5%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization-0.14%; #2559/4519 (top 56.6%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-28.84%; #4368/6202 (top 70.4%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Growth0% pass✗ 13▾

    All 8 investors flag OPTX's growth

    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: 13.4% vs Rev: -1.3%
    ✗LynchInventory growth < Revenue growth
    EPS Growth Direction$-0.01 (2022) -> $-0.05 (2025)
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency1/4 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth-1.3%
    ✗Ackman>= 5%
    Positive EPS Growth Frequency2/3 years with positive EPS growth
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 26.9% -> 23.3%, operating margin 5.2% -> -1.8%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Verdicts0% pass✗ 15▾

    Split decision: 14 FAIL · 2 NEUTRAL

    Overall verdict
    ✗GrahamFAIL (2/9)✗BuffettFAIL (0/9)✗LynchFAIL (3/7)✗GreenblattRank #1901•PiotroskiNEUTRAL (F-Score 7)✗DremanFAIL (2/11)✗MungerFAIL (1/4)✗PabraiFAIL (0/3)✗AkreFAIL (2/6)✗MarksFAIL (1/5)✗AckmanFAIL (1/9)✗TempletonFAIL (2/8)✗SleepFAIL (2/6)✗AsnessFAIL (Rank #1296/2370 (Top 54.7%))✗NeffFAIL (1/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked)
  • Valuation models0% pass✗ 4▾

    OPTX overvalued: all 4 models price fair value below $7.08 (median $0.03)

    Buffett fair value$0.06
    ✗Buffett-11700.0% margin vs $7.08
    Munger fair value$0.01
    ✗Munger-70700.0% margin vs $7.08
    Pabrai fair value$0.93
    ✗Pabrai-661.3% margin vs $7.08
    Ackman fair value$0.01
    ✗Ackman-70700.0% margin vs $7.08
  • Efficiency38% pass✓ 4✗ 7▾

    5 of 8 flag OPTX's efficiency — Buffett, Greenblatt, Munger +2 more

    Current Ratio5.97
    ✓Graham>= 2.0
    ROIC (3-5 yr avg)-3.2%
    ✗Buffett> 10%
    ROIC - WACC-13.2%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)-6.6%
    ✗Greenblatt> 25%
    Current Ratio Change YoY1.31 -> 1.35
    ✓PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY1.09x -> 1.16x
    ✓PiotroskiImproved YoY
    Current Assets / Current Liabilities5.97
    ✓Dreman> 1.5
    Return on Invested Capital-3.2%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=7.9%; FY2024: ROIC=-14.4%; FY2025: ROIC=-3.4%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROICN/A (non-positive net income)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/4 years above 12% (latest -3.4%)
    ✗SleepROIC > 12% in a majority of years
  • Cash Flow40% pass✓ 5✗ 7▾

    6 of 10 flag OPTX's cash flow — Buffett, Dreman, Pabrai +3 more

    Free Cash Flow Proxy$0.2M
    ✗BuffettPositive and growing
    FCF Positive and Growing$0.0M
    ✓LynchPositive and growing
    Operating Cash Flow$0.7M
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=2.77%, ROA=-7.38%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)389.4x
    ✗Dreman< 8x
    P/E or FCF YieldFCF Yield=0.0%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive3/4 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap-0.2%
    ✗Ackman>= 4%
    Price / FCF per Share9241.0x
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency3/4 years positive
    ✓SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$-0.4M
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization-0.14%; #2559/4519 (top 56.6%)
    ✗OshaughnessyTop 10% of eligible cross-section

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Measuring and Control Equipment
SIC Sector: Measuring & Medical Instruments
Size: Micro Cap($285.2M)
Revenue: $28.1M-1.3% YoY
Net Income: $1.8M+27.7% YoY

Financial Snapshot

Operating Margin-1.8%
Return on Equity-18.8%
Debt / Equity0.28
Current Ratio1.35
EPS (Diluted)$-0.05
Shares Retired−0.8% / −0.8% 2y

Similar Companies

TMOTHERMO FISHER SCIENTIFIC INC.
$259.4B
DHRDANAHER CORP /DE/
$163.9B
WATWATERS CORP /DE/
$90.5B
AAGILENT TECHNOLOGIES, INC.
$49.0B

Shareholder Return

Fiscal 2025

Issued 0.8% of shares last year, 0.8% issued over two.

Buybacks
—
Dividends
—

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-30

2025-10-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, operating cash flow, depreciation amortization, capex.

Q3 FY 2026

2026-07-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-03-31
FY 2024
Sources
  • 10-K · 2025-10-06
FY 2023
Sources
  • 10-K · 2024-05-23
FY 2022
Sources
  • 10-K · 2023-01-30
FY 2021
Sources
  • 10-K · 2023-01-30
Market Cap$285.2Mcurrent------$215.7Mest.$77.8Mest.$165.8Mest.$320.7Mest.--
Revenue$30.8M$8.5M↑23%$8.3M↑26%$6.5M$28.1M↓1%$28.4M↓3%$29.4M↑6%$27.8M--
Operating Income$76.3K$212.2K↑117%$321.4K↑320%-$776.0K-$517.6K↑80%-$2.6M↓267%$1.5M↑392%-$528.2K--
Net Income-$738.9K$246.6K↑117%$256.2K↑175%-$897.9K-$1.8M↑28%-$2.5M↓225%$2.0M↑555%-$434.6K--
EPS (Diluted)--$0.01↑125%$0.01↑200%$-0.02$-0.05↑29%$-0.07↓217%$0.06↑700%$-0.01--
Gross Margin22.1%22.7%↑85%25.9%↑6%14.8%23.3%↑16%20.0%↓26%26.9%↑22%22.0%—
Operating Margin0.2%2.5%↑114%3.9%↑274%-11.9%-1.8%↑80%-9.1%↓273%5.2%↑376%-1.9%—
ROE-2.4%———-18.8%↑16%-22.5%↓249%15.1%↑429%-4.6%—
Total Debt$2.6M$2.6M↓5%$2.8M↓3%$2.8M$2.6M↓15%$3.1M↑29%$2.4M↓33%$3.5M--
Shareholders' Equity$30.8M$30.8M↑214%$30.5M↑177%$8.7M$9.5M↓14%$11.0M↓16%$13.1M↑38%$9.5M↓7%$10.2M
Current Ratio7.217.21↑492%5.97↑320%1.281.35↑3%1.31↓1%1.33↑17%1.14↓65%3.27
Debt / Equity0.090.09↓70%0.09↓65%0.320.28↓1%0.28↑53%0.18↓51%0.37—
Operating Cash Flow$1.3M$1.1M↑109%-$299.0K↓89%$469.6K$672.6K↑171%-$942.8K↓134%$2.8M↑45%$1.9M--
Free Cash Flow-$357.6K$546.7K↑10%-$1.1M↓96%$175.3K$28.3K↑101%-$2.2M↓351%$871.0K↑27%$687.1K--

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Measuring and Control Equipment

OPTX vs Peers — Financial Grading

Revenue$28.1MBottom 25%
Net Income$1.8MBottom 25%
ROE-18.8%Bottom 25%
D/E0.28Top 25%
Op. Margin-1.8%Bottom 25%
Curr. Ratio1.35Bottom 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
THERMO FISHER SCIENTIFIC INC.TMO$259.4B$700.22$44.6B$6.7B12.6%0.7417.4%1.893/93/93/71/3F-Score 57/11
DANAHER CORP /DE/DHR$163.9B$233.02$24.6B$3.6B6.9%0.3519.1%1.873/94/92/71/3F-Score 54/11
WATERS CORP /DE/WAT$90.5B$460.25$3.2B$642.6M25.1%0.5525.4%1.731/94/91/70/3F-Score 45/11
AGILENT TECHNOLOGIES, INC.A$49.0B$173.96$6.9B$1.3B19.3%0.4521.3%1.962/95/93/71/3F-Score 55/11
ROPER TECHNOLOGIES INCROP$47.5B$479.98$7.9B$1.5B7.7%0.4728.3%0.522/93/93/70/3F-Score 64/11
COHERENT CORP.COHR$43.0B$218.15$5.8B$49.4M0.9%0.691.6%2.193/91/90/70/3F-Score 44/11
TERADYNE, INCTER$39.0B$249.55$3.2B$554.0M19.8%0.0720.4%1.752/96/94/71/3F-Score 66/11
ILLUMINA, INC.ILMN$31.3B$207.01$4.3B$850.0M31.2%0.7318.6%2.082/91/93/71/3F-Score 85/11